![Steven Harr](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Steven Harr
Fondatore presso
SANA BIOTECHNOLOGY, INC.
Patrimonio netto: 30 M $ in data 31/05/2026
Profilo
Steven D. Harr ha fondato Sana Biotechnology, Inc. e JW Therapeutics (Shanghai) Co. Il dottor Harr occupa la posizione di presidente, amministratore delegato e direttore di Sana Biotechnology, Inc. e di tesoriere e direttore di X-Body, Inc. È anche nel consiglio di amministrazione di JW Biotechnology (Shanghai) Co. Ltd. e Repertoire Immune Medicines, Inc. In passato ha occupato la posizione di analista di ricerca presso Morgan Stanley & Co. LLC, Chief Financial Officer & Head-Development presso Juno Therapeutics, Inc. e Director presso JW Therapeutics (Shanghai) Co. Il dottor Harr ha conseguito una laurea presso il College of the Holy Cross (Massachusetts) e un dottorato presso la Johns Hopkins University School of Medicine.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 30/03/2026 | 8.960.751 ( 3,46% ) | 30 M $ | 31/05/2026 |
Posizioni attive di Steven Harr
| Società | Posizione | Inizio |
|---|---|---|
| SANA BIOTECHNOLOGY, INC. | Fondatore | 13/07/2018 |
JW Biotechnology (Shanghai) Co. Ltd. | Direttore/Membro del Consiglio | - |
X-Body, Inc.
 X-Body, Inc. BiotechnologyHealth Technology Provides biotechnological research services | Direttore/Membro del Consiglio | - |
Repertoire Immune Medicines, Inc.
 Repertoire Immune Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that engages in immune medicines to prevent, treat and cure cancer | Direttore/Membro del Consiglio | 01/03/2020 |
Cobalt Biomedicine, Inc.
 Cobalt Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing therapeutic based drugs | Presidente | - |
Precedenti posizioni note di Steven Harr
| Società | Posizione | Fine |
|---|---|---|
| LOXO ONCOLOGY INC | Direttore/Membro del Consiglio | 15/02/2019 |
JW Therapeutics (Shanghai) Co., Ltd.
 JW Therapeutics (Shanghai) Co., Ltd. BiotechnologyHealth Technology Develops cell-based immunotherapies to treat cancer | Fondatore | 25/09/2018 |
| JUNO THERAPEUTICS INC | Direttore Finanziario/CFO | 01/03/2018 |
Morgan Stanley & Co. LLC
 Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Amministratore Delegato | 01/04/2014 |
| ░░ ░░░░░░░░ ░░░░░░░░░░░░ ░░░ ░░░ | ░░░░░░░░░ | - |
Formazione di Steven Harr
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
86
Relazioni di 1° grado
12
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 12 |
|---|---|
X-Body, Inc.
X-Body, Inc. BiotechnologyHealth Technology Provides biotechnological research services | Health Technology |
Morgan Stanley & Co. LLC
Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
College of the Holy Cross (Massachusetts)
 College of the Holy Cross (Massachusetts) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Loxo Oncology, Inc.
 Loxo Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops medicine for cancer treatment | Health Technology |
The Johns Hopkins University School of Medicine
 The Johns Hopkins University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Juno Therapeutics, Inc.
 Juno Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company to treat cancer, HIV and cardiovascular diseases | Health Technology |
JW Biotechnology (Shanghai) Co. Ltd. | |
JW Therapeutics (Shanghai) Co., Ltd.
JW Therapeutics (Shanghai) Co., Ltd. BiotechnologyHealth Technology Develops cell-based immunotherapies to treat cancer | Health Technology |
JW (Cayman) Therapeutics Co. Ltd.
 JW (Cayman) Therapeutics Co. Ltd. BiotechnologyHealth Technology Operates as biotechnology company that develops and manufactures cell immunotherapy products | Health Technology |
Sana Biotechnology, Inc.
 Sana Biotechnology, Inc. BiotechnologyHealth Technology Operates as a biotechnological company which creates and delivers engineered cells as medicine for patients | Health Technology |
Cobalt Biomedicine, Inc.
Cobalt Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing therapeutic based drugs | Health Technology |
Repertoire Immune Medicines, Inc.
Repertoire Immune Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that engages in immune medicines to prevent, treat and cure cancer | Health Technology |
